Preferred Label : Epidermolytic hyperkeratosis 1;
Symbol : EHK1;
CISMeF acronym : BCIE; BIE; EHK;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Bullous erythroderma ichthyosiformis congenita of brocq; Bullous congenital ichthyosiform erythroderma; Bullous ichthyosiform erythroderma; Epidermolytic ichthyosis; BCIE; BIE; EI;
Description : Epidermolytic hyperkeratosis (EHK), also termed bullous congenital ichthyosiform erythroderma
(BCIE), is a keratinization disorder with an incidence of approximately 1 in 200,000
in the USA. The clinical phenotype of EHK is characterized by erythema and widespread
formation of epidermal blisters developing at birth. Later in life, bullous erythema
is replaced by progressive hyperkeratosis, involving thickening of the cornified layer
of the epidermis (summary by Muller et al., 2006). Goldsmith (1976) used the designation
of epidermolytic hyperkeratosis for the condition that is called bullous congenital
ichthyosiform erythroderma (BCIE) when generalized, and ichthyosis hystrix (see 146600)
when localized. They are presumably distinct entities. A form of epidermolytic hyperkeratosis
that is limited to the palms and soles, designated palmoplantar keratoderma (EPPK;
144200), is caused by mutation in the keratin gene KRT9 (607606), and a mild form
of EPPK can also be caused by mutation in KRT1.;
Inheritance : Autosomal recessive (in some families); Autosomal dominant;
Molecular basis : Caused by mutation in the keratin 1 gene (KRT1, 139350.0001); Caused by mutation in the keratin 10 gene (KRT10, 148080.0001);
Prefixed ID : #113800;
Origin ID : 113800;
UMLS CUI : C5781874;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
False automatic mappings
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT